ABL1 | ABL proto-oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
AMER1 | APC membrane recruitment protein 1 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Mixed |
ARID1A | AT rich interactive domain 1A (SWI-like) | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
ATM | ATM serine/threonine kinase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
AXIN1 | Axin 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BAP1 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
BIRC3 | Baculoviral IAP repeat containing 3 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BLM | Bloom syndrome, RecQ helicase-like | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Mixed |
BRCA2 | Breast cancer 2, early onset | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CBL | Cbl proto-oncogene, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Mixed |
CBLB | Cbl proto-oncogene B, E3 ubiquitin protein ligase | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CDC73 | Cell division cycle 73 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDK12 | Cyclin-dependent kinase 12 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CDKN2A | Cyclin-dependent kinase inhibitor 2A | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
CIC | Capicua transcriptional repressor | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
CREBBP | CREB binding protein | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CUX1 | Cut-like homeobox 1 | Cancer-related genes Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
CYLD | Cylindromatosis (turban tumor syndrome) | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DAXX | Death-domain associated protein | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
DDB2 | Damage-specific DNA binding protein 2, 48kDa | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
DICER1 | Dicer 1, ribonuclease type III | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DNM2 | Dynamin 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EP300 | E1A binding protein p300 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ERCC3 | Excision repair cross-complementation group 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ERCC4 | Excision repair cross-complementation group 4 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
EZH2 | Enhancer of zeste 2 polycomb repressive complex 2 subunit | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
FANCA | Fanconi anemia, complementation group A | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
FANCC | Fanconi anemia, complementation group C | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FANCD2 | Fanconi anemia, complementation group D2 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Mixed |
FANCG | Fanconi anemia, complementation group G | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Mixed |
FAS | Fas cell surface death receptor | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
FBXO11 | F-box protein 11 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FBXW7 | F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FH | Fumarate hydratase | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
FLCN | Folliculin | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
FOXA1 | Forkhead box A1 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
FOXL2 | Forkhead box L2 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
GATA2 | GATA binding protein 2 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |